|
| 37740924 | ATN cerebrospinal fluid biomarkers in dementia with Lewy bodies: Initial results from the United States Dementia with Lewy Bodies Consortium. | Alzheimers Dement | 2024 |
| 37461624 | Multi-ancestry genome-wide meta-analysis of 56,241 individuals identifies <i>LRRC4C, LHX5-AS1</i> and nominates ancestry-specific loci <i>PTPRK</i> , <i>GRB14</i> , and <i>KIAA0825</i> as novel risk loci for Alzheimer's disease: the Alzheimer's Disease Genetics Consortium. | medRxiv | 2023 |
| 37491668 | Cerebrospinal fluid biomarkers in the Longitudinal Early-onset Alzheimer's Disease Study. | Alzheimers Dement | 2023 |
| 37491599 | White matter hyperintensities are higher among early-onset Alzheimer's disease participants than their cognitively normal and early-onset nonAD peers: Longitudinal Early-onset Alzheimer's Disease Study (LEADS). | Alzheimers Dement | 2023 |
| 37801072 | Pathogenic variants in the Longitudinal Early-onset Alzheimer's Disease Study cohort. | Alzheimers Dement | 2023 |
| 37662203 | Lysophosphatidylcholines are associated with P-tau181 levels in early stages of Alzheimer's Disease. | medRxiv | 2023 |
| 37554284 | Focused ultrasound mitigates pathology and improves spatial memory in Alzheimer's mice and patients. | Theranostics | 2023 |
| 37850549 | The Sporadic Early-onset Alzheimer's Disease Signature Of Atrophy: Preliminary Findings From The Longitudinal Early-onset Alzheimer's Disease Study (LEADS) Cohort. | Alzheimers Dement | 2023 |
| 37653686 | Influence of amyloid and diagnostic syndrome on non-traditional memory scores in early-onset Alzheimer's disease. | Alzheimers Dement | 2023 |
| 37581299 | Neurofilament light chain: A potential biomarker for cerebrovascular disease in children with sickle cell anaemia. | Br J Haematol | 2023 |
| 37690109 | Amyloid and tau-PET in early-onset AD: Baseline data from the Longitudinal Early-onset Alzheimer's Disease Study (LEADS). | Alzheimers Dement | 2023 |
| 37645764 | Risk of Alzheimer's Disease is Associated with Longitudinal Changes in Plasma Biomarkers in the Multiethnic Washington Heights, Inwood Columbia Aging Project Cohort. | medRxiv | 2023 |
| 37496307 | Sex and APOE ε4 carrier effects on atrophy, amyloid PET, and tau PET burden in early-onset Alzheimer's disease. | Alzheimers Dement | 2023 |
| 37256497 | Profiling baseline performance on the Longitudinal Early-Onset Alzheimer's Disease Study (LEADS) cohort near the midpoint of data collection. | Alzheimers Dement | 2023 |
| 36949897 | ARIA in patients treated with lecanemab (BAN2401) in a phase 2 study in early Alzheimer's disease. | Alzheimers Dement (N Y) | 2023 |
| 37386610 | The neuropathological landscape of Hispanic and non-Hispanic White decedents with Alzheimer disease. | Acta Neuropathol Commun | 2023 |
| 37079306 | Evaluation of Plasma Biomarkers for A/T/N Classification of Alzheimer Disease Among Adults of Caribbean Hispanic Ethnicity. | JAMA Netw Open | 2023 |
| 37243937 | Learning slopes in early-onset Alzheimer's disease. | Alzheimers Dement | 2023 |
| 37296082 | Baseline neuropsychiatric symptoms and psychotropic medication use midway through data collection of the Longitudinal Early-Onset Alzheimer's Disease Study (LEADS) cohort. | Alzheimers Dement | 2023 |
| 34057284 | Patterns of tau pathology identified with <sup>18</sup> F-MK-6240 PET imaging. | Alzheimers Dement | 2022 |
| 35783127 | Avoid or Embrace? Practice Effects in Alzheimer's Disease Prevention Trials. | Front Aging Neurosci | 2022 |
| 35360274 | Blood-Based Biomarkers for Alzheimer's Disease in Older Adults with Posttraumatic Stress Disorder. | J Alzheimers Dis Rep | 2022 |
| 35389045 | Wolframin is a novel regulator of tau pathology and neurodegeneration. | Acta Neuropathol | 2022 |
| 36123123 | Longitudinal Patterns of Cortical Atrophy on MRI in Patients With Alzheimer Disease With and Without Lewy Body Pathology. | Neurology | 2022 |
| 36121669 | Evaluating the Safety and Efficacy of Crenezumab vs Placebo in Adults With Early Alzheimer Disease: Two Phase 3 Randomized Placebo-Controlled Trials. | JAMA Neurol | 2022 |
| 36151869 | Amyloid-Related Imaging Abnormalities in the DIAN-TU-001 Trial of Gantenerumab and Solanezumab: Lessons from a Trial in Dominantly Inherited Alzheimer Disease. | Ann Neurol | 2022 |
| 35306760 | Correlation of plasma and neuroimaging biomarkers in Alzheimer's disease. | Ann Clin Transl Neurol | 2022 |
| 35173668 | Fluid and Tissue Biomarkers of Lewy Body Dementia: Report of an LBDA Symposium. | Front Neurol | 2022 |
| 33367843 | Early Selective Vulnerability of the CA2 Hippocampal Subfield in Primary Age-Related Tauopathy. | J Neuropathol Exp Neurol | 2021 |
| 33646153 | Olfactory Impairment Is Related to Tau Pathology and Neuroinflammation in Alzheimer's Disease. | J Alzheimers Dis | 2021 |
| 33589841 | Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture. | Nat Genet | 2021 |
| 33580742 | Plasma p-tau181, p-tau217, and other blood-based Alzheimer's disease biomarkers in a multi-ethnic, community study. | Alzheimers Dement | 2021 |
| 34018654 | The Longitudinal Early-onset Alzheimer's Disease Study (LEADS): Framework and methodology. | Alzheimers Dement | 2021 |
| 34155411 | A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer's disease. | Nat Med | 2021 |
| 33278686 | Anterolateral entorhinal cortex volume is associated with memory retention in clinically unimpaired older adults. | Neurobiol Aging | 2021 |
| 32342830 | Leukocyte Telomere Length Is Unrelated to Cognitive Performance Among Non-Demented and Demented Persons: An Examination of Long Life Family Study Participants. | J Int Neuropsychol Soc | 2020 |
| 31996268 | Analysis of neurodegenerative disease-causing genes in dementia with Lewy bodies. | Acta Neuropathol Commun | 2020 |
| 33239387 | Tau and other proteins found in Alzheimer's disease spinal fluid are linked to retromer-mediated endosomal traffic in mice and humans. | Sci Transl Med | 2020 |
| 32594908 | Allele-specific DNA methylation is increased in cancers and its dense mapping in normal plus neoplastic cells increases the yield of disease-associated regulatory SNPs. | Genome Biol | 2020 |
| 32241955 | Research criteria for the diagnosis of prodromal dementia with Lewy bodies. | Neurology | 2020 |
| 32568196 | Safety, Tolerability, and Pharmacokinetics of Crenezumab in Patients with Mild-to-Moderate Alzheimer's Disease Treated with Escalating Doses for up to 133Â Weeks. | J Alzheimers Dis | 2020 |
| 30448004 | A comprehensive screening of copy number variability in dementia with Lewy bodies. | Neurobiol Aging | 2019 |
| 31520793 | Cerebrospinal fluid amyloid levels are associated with delayed memory retention in cognitively normal biomarker-negative older adults. | Neurobiol Aging | 2019 |
| 30953760 | Heritability and genetic variance of dementia with Lewy bodies. | Neurobiol Dis | 2019 |
| 30867052 | Lewy Body Dementia Association's Research Centers of Excellence Program: Inaugural Meeting Proceedings. | Alzheimers Res Ther | 2019 |
| 30739198 | Genome-wide analyses as part of the international FTLD-TDP whole-genome sequencing consortium reveals novel disease risk factors and increases support for immune dysfunction in FTLD. | Acta Neuropathol | 2019 |
| 31122495 | Safety of the tau-directed monoclonal antibody BIIB092 in progressive supranuclear palsy: a randomised, placebo-controlled, multiple ascending dose phase 1b trial. | Lancet Neurol | 2019 |
| 30883364 | Role of Amyloid-β and Tau Proteins in Alzheimer's Disease: Confuting the Amyloid Cascade. | J Alzheimers Dis | 2019 |
| 30937451 | Predicting Cognitive Improvement in Normal Pressure Hydrocephalus Patients Using Preoperative Neuropsychological Testing and Cerebrospinal Fluid Biomarkers. | Neurosurgery | 2019 |
| 30820047 | Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing. | Nat Genet | 2019 |